TSXV - Delayed Quote CAD
NurExone Biologic Inc. (NRX.V)
0.6400
-0.0100
(-1.54%)
At close: April 24 at 11:34:22 AM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
2,441
2,170
2,794
2,836
Total Liabilities Net Minority Interest
680
1,981
698
1,659
Total Equity Gross Minority Interest
1,761
189
2,096
1,177
Total Capitalization
1,761
189
2,096
1,177
Common Stock Equity
1,761
189
2,096
1,177
Capital Lease Obligations
33
20
44
--
Net Tangible Assets
1,761
189
2,096
1,177
Working Capital
1,236
74
2,089
1,205
Invested Capital
1,761
189
2,096
2,220
Tangible Book Value
1,761
189
2,096
1,177
Total Debt
33
20
44
1,043
Share Issued
70,517.0030
48,249.7070
42,855.1580
42,855.1580
Ordinary Shares Number
70,517.0030
48,249.7070
42,855.1580
42,855.1580
12/31/2021 - 9/13/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NRXPW NRx Pharmaceuticals, Inc.
0.0598
-3.55%
MOOD.CN Doseology Sciences Inc.
0.1600
0.00%
NURL.CN NeuralThera
0.0400
+14.29%
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.49
+3.98%
COV.V Covalon Technologies Ltd.
2.2950
+1.10%
TH.TO Theratechnologies Inc.
3.9100
+3.17%
OSRH OSR Holdings, Inc.
1.3800
+0.73%
AVTE Aerovate Therapeutics, Inc.
2.7200
-0.73%
ONC.TO Oncolytics Biotech Inc.
0.8100
-3.57%
MDNA.TO Medicenna Therapeutics Corp.
1.0500
0.00%